CMC 02-003 “Study of Stereotactic Body Radiotherapy for Recurrent and Metastatic Lesions to the Lung, Liver, Spine and Viscera”
RTOG 0413/B39 “A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I or II Breast Cancer”
RTOG 0320 “A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients with Non-Small Cell Lung Cancer and 1-3 Brain Metastases”
RTOG 0235 “Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma”
PACCT-1/TAILORx: “Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment”
CALGB 80405: “A Phase III Trial of Irinotecan/5FU/Leukovorin or Oxaliplatin/5FU/Leukovorin With Bevacizumab or Cetuximab (C225), 0r with the combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum” suspended
SWOG 0226: “Phase III Randomized Trial of Anastrozole versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women with Metastatic Breast Cancer”
SWOG S0307: “Phase III Trial of Biphosphonates as Adjuvant Therapy for Primary Breast Cancer”
ECOG E5202: “A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers”
RTOG 0522: “A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas”
GOG 0218: “A Phase III Trial of Carboplatin and Paclitaxel plus Placebo vs. Carboplatin and Paclitaxel plus Concurrent Bevacizumab (NSC#704865, IND #7921) followed by Placebo, vs. Carboplatin and Paclitaxel plus Concurrent and Extended Bevacizumab, in Women with Newly Diagnosed, Previously Untreated, Stage III (Suboptimal) and All Stage IV, Epithelial Ovarian or Primary Peritoneal Cancer”
ECOG E2805: “A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma”
GOG 0219: “A Phase III, Randomized Trial of Weekly Cisplatin and Radiation vs. Cisplatin and Tirapazamine and Radiation in Stage IB2, IIB, IIIB, IVA Cervical Carcinoma Limited to the Pelvis”
RTOG 0415: “A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT versus Conventionally Fractionated 3D-CRT/IMRT in Patients with Favorable-Risk Prostate Cancer”
SWOG S0424: “Molecular Epidemiology Case-Studies Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Woman and Men”
IRB 07-014: “Phase III Randomized Study of Calendula vs. Biafine to Prevent Radiation-Induced Dermatitis”
RTOG 0617: “A Randomized Phase III Comparison of Standard-Dose (60Gy) versus High-Dose (74Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer”
RTOG 0615: “A Phase II Study of Concurrent Chemoradiotherapy Using three-Dimensional Conformal Radiotherapy (3D-RT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) {NSC 708865; IND 7921} for locally or Regionally Advanced Nasopharyngeal cancer”
RTOG 0433: “ A Phase III International Randomized Trial of Single Versus Multiple Fractions For Re-Irradiation of Painful Bone Metastases”
RTOG 0436: “a Phase III Teial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin and Radiation for Patients with Esophageal Cancer Who Are Treated Without Surgery”
FER-HO-001: “Measuring Quality Improvement in Breast Cancer Care and Management Throughout Fox Chase Cancer Center Partners’ Hospitals”
[ medical services index ] [ top ] |
